'Getting there': the impact of structured insulin management education in a high ethnic mix population with type 1 and type 2 diabetes

被引:1
|
作者
Fairfield, Jane [1 ]
Amin, Sayjal [1 ]
James, June [1 ]
机构
[1] Univ Hosp Leicester NHS Trust, Leicester Gen Hosp, Dept Endocrinol & Diabet, Gwendolen Rd, Leicester LE4 5PW, Leics, England
关键词
type 1 and type 2 diabetes; insulin management; group education; high ethnic mix population;
D O I
10.1002/pdi.1831
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Structured education programmes support and enable people with diabetes to develop self-management skills. Insulin management central to DAFNE is restricted to those with type 1 diabetes of at least six months' duration and on multiple dose regimens. DESMOND is available for all with type 2 diabetes but does not include guidance on how to self-manage diabetes with insulin. Our aims were to develop an education programme for people with type 1 or 2 diabetes already on insulin and who may be using a variety of insulin regimens, to enable effective self-management, improve confidence, reduce hypoglycaemia and enable peer group support. An evidence-based curriculum, developed in line with NICE principles, was piloted. This consisted of three half-day sessions held during a one-month period with up to 10 participants and supporters invited to attend. Four further programmes were held; education was tailored to the individual needs of groups and verbal evaluation was undertaken. Anonymised patient satisfaction questionnaires were posted at programme completion. Audit included clinical data, demographics, patient satisfaction and health care professional assessment of content. There were 40 participants over five courses; 20% (n=8) were type 1, 68% (n=27) were male, average age was 58 years ( range 35-82 years), and 55% were South Asian (n=22). In 38 of 40 participants where a recorded pre-and three months post-intervention was available, an average HbAic reduction of 1.18% was achieved - i.e. 9.02% reduced to 7.84% (75.1 mmol/mol reduced to 62.2mmol/mol). Twenty-five participants (62.5%) returned the survey form: 96% (24/25) said diabetes control improved, and all felt more confident to adjust insulin; 96% (23/24) felt more confident to treat 'hypos' (one stated 'hypos' had not reduced) and 96% (24/25) felt they learned more by attending the programme. This programme met participants' individual needs, increased confidence in insulin management and improved glycaemic control in a high ethnic mix poulation. Copyright (C) 2014 John Wiley & Sons.
引用
收藏
页码:54 / 57
页数:4
相关论文
共 50 条
  • [31] Treatment of type 2 diabetes: a structured management plan
    Mike Baxter
    Advances in Therapy, 2008, 25 : 106 - 114
  • [32] Role of depression in diabetes management in an ethnic minority population: a case of Korean Americans with type 2 diabetes
    Kim, Miyong To
    Kim, Kim Byeng
    Ko, Jisook
    Jang, Yuri
    Levine, David
    Lee, Hochang Benjamin
    BMJ OPEN DIABETES RESEARCH & CARE, 2017, 5 (01)
  • [33] The impact of a validated structured education programme diabetes-related distress in patients with type 2 diabetes
    Cardwell, J.
    Crooks, N.
    Bujawansa, S.
    McNulty, S.
    Furlong, N.
    Narayanan, R. P.
    Jackson, J.
    Mitchell, L.
    Westall, S. J.
    Hardy, K.
    DIABETIC MEDICINE, 2020, 37 : 101 - 101
  • [34] Evaluation of Structured Education Programme for Patients with Type 1 Diabetes
    Newman, C.
    Condron, A.
    McQuaid, S. E.
    IRISH JOURNAL OF MEDICAL SCIENCE, 2018, 187 : S216 - S217
  • [35] Management of type 2 diabetes: Patient education
    Meillet, Lucie
    Combes, Jerome
    Penfornis, Alfred
    PRESSE MEDICALE, 2013, 42 (05): : 880 - 885
  • [36] Insulin detemir in the treatment of type 1 and type 2 diabetes
    Philips, Jean-Christophe
    Scheen, Andre
    VASCULAR HEALTH AND RISK MANAGEMENT, 2006, 2 (03) : 277 - 283
  • [37] Insulin glulisine - Treatment of type 1 and type 2 diabetes
    Sorbera, LA
    Leeson, PA
    DRUGS OF THE FUTURE, 2003, 28 (11) : 1055 - 1058
  • [38] Intensive insulin therapy in type 1 and type 2 diabetes
    Dean, J
    Sharp, P
    HOSPITAL MEDICINE, 2004, 65 (05): : 288 - 292
  • [39] Insulin glargine in the treatment of type 1 and type 2 diabetes
    Barnett, Anthony
    VASCULAR HEALTH AND RISK MANAGEMENT, 2006, 2 (01) : 59 - 67
  • [40] DAFNE (Dose Adjustment for Normal Eating): structured education in insulin replacement therapy for type 1 diabetes
    McIntyre, H. David
    MEDICAL JOURNAL OF AUSTRALIA, 2006, 184 (07) : 317 - 318